Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
for Hematologic Neoplasms
1 location in Bethesda
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 12 - 120·Accepts healthy volunteers
Code: NCT05327023·Phase 1, Phase 2·Recruiting